María L. Amador
Asociación Española Contra el Cáncer(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → An In vivo Platform for Translational Drug Development in Pancreatic Cancer(2006)412 cited
- → An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors(2004)242 cited
- → A prospective phase II trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients (p) with mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR)(2006)162 cited
- → Progress in the development and acquisition of anticancer agents from marine sources(2003)150 cited
- → Epidermal Growth Factor Receptor Dynamics Influences Response to Epidermal Growth Factor Receptor Targeted Agents(2005)105 cited
- → Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy(2011)64 cited
- → Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy(2004)63 cited
- → Physiological and biochemical parameters controlling waterlogging stress tolerance in Prunus before and after drainage(2012)59 cited
- → Impact of the COVID-19 pandemic on the care of cancer patients in Spain(2021)55 cited
- → ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer(2024)46 cited